Head & Neck Cancer

Your multidisciplinary team of head and neck cancer specialists provides seamless care in as few visits as possible, as well as customized treatment based on the location of the tumor and how advanced it is. The team may include otolaryngologists, head and neck surgeons, reconstructive surgeons, plastic surgeons, oral-maxillofacial surgeons, endocrine surgeons, radiation and medical oncologists, and speech and swallowing therapists.

We offer advanced diagnostic tools, including PET/MRI, and targeted treatments such as immunotherapy and brachytherapy to deliver radiation therapy directly to the tumor. Our surgeons are pioneers in reconstructive surgical techniques, which may be an important part of your care.

Throughout treatment and recovery, we provide compassionate care and support services, such as speech and swallowing therapy.

Clinical Trials and Research Studies

Phase 1/2

A Phase 1/2 Study Exploring the Safety Tolerability and Efficacy of INCAGN01949 in Combination With Immune Therapies in Subjects With Advanced or Metastatic Malignancies

Learn More

Phase 1

A PHASE I AND EXPANSION COHORT STUDY OF ADJUVANT CISPLATIN INTENSITY-MODULATED RADIOTHERAPY AND MK-3475 (PEMBROLIZUMAB) IN HIGH-RISK HEAD AND NECK SQUAMOUS CELL CARCINOMA (HNSCC)

Learn More

Phase 1

A Phase 1 Open-Label Multicenter Study to Assess the Safety Tolerability and Immunogenicity of mRNA-4157 Alone in Subjects with Resected Solid Tumors and in Combination with Pembrolizumab in Subjects with Unresectable Solid Tumors

Learn More

Phase 1

A Phase 1 Open-Label Dose-Escalation and Cohort Expansion First-in-Human Study of the Safety Tolerability Activity and Pharmacokinetics of REGN3767 (anti-LAG-3 mAb) Administered Alone or in Combination with REGN2810 (anti-PD-1 mAb) in Patients with Ad

Learn More